Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
04:19 EDT 17 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2012 /PRNewswire/ -- Trellis Bioscience LLC, a private company discovering and developing novel human antibody therapeutics for the treatment of infectious disease and cancer, has been awarded a Small Business In...
Other Sources for this Article
More From BioPortfolio on "Trellis Bioscience Awarded SBIR Grant to Advance CMV Program"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
